Indocyanine green acid form
- Generic Name
- Indocyanine green acid form
- Brand Names
- Ic-green
- Drug Type
- Small Molecule
- Chemical Formula
- C43H48N2O6S2
- CAS Number
- 28782-33-4
- Unique Ingredient Identifier
- C4V974V932
- Background
Indocyanine Green is a water soluble, tricarbocyanine dye with a peak spectral absorption at 800 nm. The chemical name for Indocyanine Green is 1 H-Benz[e]indolium, 2-[7-[1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benz[e] indol-2-ylidene]-1,3,5-heptatrienyl]-1,1-dimethyl-3-(4-sulfobutyl)-,hydroxide, inner salt, sodium salt. Indocyanine Green for Injection USP has a pH of approximately 6.5 when reconstituted. Each vial of Indocyanine Green for Injection USP contains 25 mg of Indocyanine Green as a sterile lyophilized powder with no more than 5% sodium iodide.
- Indication
For Determining Cardiac Output, Hepatic Function and Liver Blood Flow
For ophthalmic angiography
Indocyanine Green Fluorescent Molecular Imaging of the Gastrointestinal Tract
- Conditions
- Colorectal PolypsDistal Colonic LesionsHigh Risk Polyposis Syndrome
- Interventions
- First Posted Date
- 2010-04-28
- Last Posted Date
- 2014-02-24
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 4
- Registration Number
- NCT01112514
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Advanced Gastrointestinal Endoscopic Imaging
- Conditions
- Gastrointestinal DiseasesGastrointestinal Stromal Tumor (GIST)Gastric (Stomach) Cancer
- Interventions
- Device: Dual axis endoscopic microscopeDevice: wide field fluorescence systemDevice: CellVizio
- First Posted Date
- 2009-12-17
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 3
- Registration Number
- NCT01034670
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction
- Conditions
- Unspecified Adult Solid Tumor, Protocol SpecificLung Cancer
- Interventions
- Other: high performance liquid chromatographyOther: intracellular fluorescence polarization analysisOther: liquid chromatographyOther: mass spectrometryOther: pharmacological study
- First Posted Date
- 2007-10-08
- Last Posted Date
- 2019-03-11
- Lead Sponsor
- City of Hope Medical Center
- Target Recruit Count
- 47
- Registration Number
- NCT00540982
- Locations
- 🇺🇸
City of Hope Medical Group, Pasadena, California, United States
🇺🇸City of Hope Comprehensive Cancer Center, Duarte, California, United States
Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin
- Conditions
- Melanoma (Skin)Metastatic Cancer
- First Posted Date
- 2007-03-28
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 11
- Registration Number
- NCT00453050
- Locations
- 🇺🇸
Oklahoma University Cancer Institute, Tulsa, Oklahoma, United States
Insulin on Post Burn Hypermetabolism
- Conditions
- Burns
- Interventions
- First Posted Date
- 2005-08-29
- Last Posted Date
- 2012-04-12
- Lead Sponsor
- United States Army Institute of Surgical Research
- Target Recruit Count
- 14
- Registration Number
- NCT00137254
- Locations
- 🇺🇸
US Army Institute of Surgical Research, Fort Sam Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.